tiprankstipranks
Advertisement
Advertisement

CPRX Stock Latest News

Analyst Initiates Buy on Catalyst Pharma, Citing M&A Appeal, Rare Disease Growth and $35 Price Target Backed by Strong Balance Sheet
RatingsAnalyst Initiates Buy on Catalyst Pharma, Citing M&A Appeal, Rare Disease Growth and $35 Price Target Backed by Strong Balance Sheet
8d ago
CPRX
Angelini exploring acquisition of Catalyst Pharmaceuticals, Bloomberg says
PremiumThe Fly
Angelini exploring acquisition of Catalyst Pharmaceuticals, Bloomberg says
8d ago
CPRX
Catalyst Pharmaceuticals trading resumes
PremiumThe Fly
Catalyst Pharmaceuticals trading resumes
9d ago
CPRX
Catalyst Pharmaceuticals trading halted, volatility trading pause
PremiumThe Fly
Catalyst Pharmaceuticals trading halted, volatility trading pause
9d ago
CPRX
Catalyst Pharma Patent Trial Against Hetero USA Delayed
PremiumCompany Announcements
Catalyst Pharma Patent Trial Against Hetero USA Delayed
2M ago
8K
CPRX
Catalyst Pharmaceutical Partners Signals Confident Growth Path
PremiumCompany AnnouncementsCatalyst Pharmaceutical Partners Signals Confident Growth Path
2M ago
CPRX
Buy Rating on Catalyst Pharma Driven by Strong 2026 Growth Outlook and Favorable Firdapse Litigation Upside
Premium
Ratings
Buy Rating on Catalyst Pharma Driven by Strong 2026 Growth Outlook and Favorable Firdapse Litigation Upside
2M ago
CPRX
Catalyst Pharmaceuticals price target raised to $35 from $33 at Citi
Premium
The Fly
Catalyst Pharmaceuticals price target raised to $35 from $33 at Citi
2M ago
CPRX
Buy Rating on Catalyst Pharma Backed by Strong Growth, Underpenetrated LEMS Opportunity, and Rising Profitability Post-Royalty Roll-Off
PremiumRatings
Buy Rating on Catalyst Pharma Backed by Strong Growth, Underpenetrated LEMS Opportunity, and Rising Profitability Post-Royalty Roll-Off
2M ago
CPRX
Catalyst Pharma Posts Record 2025 Results, Raises 2026 Outlook
PremiumCompany Announcements
Catalyst Pharma Posts Record 2025 Results, Raises 2026 Outlook
2M ago
8K
CPRX
Catalyst Pharmaceuticals reports Q4 EPS 68c, consensus 50c
PremiumThe Fly
Catalyst Pharmaceuticals reports Q4 EPS 68c, consensus 50c
2M ago
CPRX
Catalyst Pharmaceuticals sees FY26 revenue $615M-$645M, consensus $615.58M
PremiumThe Fly
Catalyst Pharmaceuticals sees FY26 revenue $615M-$645M, consensus $615.58M
2M ago
CPRX
Is CPRX a Buy, Before Earnings?
PremiumPre-EarningsIs CPRX a Buy, Before Earnings?
2M ago
CPRX
Catalyst Pharmaceuticals: Rare-Disease Buy-and-Build Strategy, Strong Launches, and Capital Flexibility Underpin Buy Rating
Premium
Ratings
Catalyst Pharmaceuticals: Rare-Disease Buy-and-Build Strategy, Strong Launches, and Capital Flexibility Underpin Buy Rating
4M ago
CPRX
Catalyst Pharma Highlights Growth Strategy at J.P. Morgan Conference
Premium
Company Announcements
Catalyst Pharma Highlights Growth Strategy at J.P. Morgan Conference
4M ago
8K
CPRX
Catalyst Pharmaceuticals Reports Strong Q3 2025 Earnings
PremiumCompany Announcements
Catalyst Pharmaceuticals Reports Strong Q3 2025 Earnings
6M ago
CPRX
Catalyst Pharma’s Strategic Growth and Market Positioning: A Promising Outlook
PremiumRatings
Catalyst Pharma’s Strategic Growth and Market Positioning: A Promising Outlook
6M ago
CPRX
Catalyst Pharmaceuticals price target raised to $33 from $32 at Oppenheimer
PremiumThe Fly
Catalyst Pharmaceuticals price target raised to $33 from $32 at Oppenheimer
6M ago
CPRX
Catalyst Pharmaceuticals price target raised to $33 from $31 at Citi
PremiumThe Fly
Catalyst Pharmaceuticals price target raised to $33 from $31 at Citi
6M ago
CPRX
Catalyst Pharmaceuticals Reports Strong Q3 2025 Results
PremiumCompany AnnouncementsCatalyst Pharmaceuticals Reports Strong Q3 2025 Results
6M ago
CPRX
Catalyst Pharmaceuticals reports Q3 EPS 68c, consensus 54c
Premium
The Fly
Catalyst Pharmaceuticals reports Q3 EPS 68c, consensus 54c
6M ago
CPRX
Catalyst Pharma Reports Strong Q3 2025 Financial Results
Premium
Company Announcements
Catalyst Pharma Reports Strong Q3 2025 Financial Results
6M ago
8K
CPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >